Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease.

Lu MH, Zhao XY, Yao PP, Xu DE, Ma QH.

Neurosci Bull. 2018 Dec;34(6):1127-1130. doi: 10.1007/s12264-018-0310-y. Epub 2018 Nov 12. Review. No abstract available.

PMID:
30417261
2.

Inflammation: the link between comorbidities, genetics, and Alzheimer's disease.

Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R.

J Neuroinflammation. 2018 Sep 24;15(1):276. doi: 10.1186/s12974-018-1313-3. Review.

3.

Biomarkers of dementia in obstructive sleep apnea.

Baril AA, Carrier J, Lafrenière A, Warby S, Poirier J, Osorio RS, Ayas N, Dubé MP, Petit D, Gosselin N; Canadian Sleep and Circadian Network.

Sleep Med Rev. 2018 Dec;42:139-148. doi: 10.1016/j.smrv.2018.08.001. Epub 2018 Aug 13. Review.

PMID:
30241998
4.

Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study.

Zhou L, Li HY, Wang JH, Deng ZZ, Shan YL, Tan S, Shi YH, Zhang MX, Liu SX, Zhang BJ, Hong MF, Lu ZQ, Huang XM.

Medicine (Baltimore). 2018 Sep;97(38):e12470. doi: 10.1097/MD.0000000000012470.

5.

Epileptic seizures in autosomal dominant forms of Alzheimer's disease.

Cortini F, Cantoni C, Villa C.

Seizure. 2018 Oct;61:4-7. doi: 10.1016/j.seizure.2018.07.015. Epub 2018 Jul 19. Review.

PMID:
30041064
6.

Low expression of aging-related NRXN3 is associated with Alzheimer disease: A systematic review and meta-analysis.

Zheng JJ, Li WX, Liu JQ, Guo YC, Wang Q, Li GH, Dai SX, Huang JF.

Medicine (Baltimore). 2018 Jul;97(28):e11343. doi: 10.1097/MD.0000000000011343. Review.

7.

Untangling the Tauopathy for Alzheimer's disease and parkinsonism.

Chang HY, Sang TK, Chiang AS.

J Biomed Sci. 2018 Jul 10;25(1):54. doi: 10.1186/s12929-018-0457-x. Review.

8.

Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.

Goldman JS, Van Deerlin VM.

Mol Diagn Ther. 2018 Oct;22(5):505-513. doi: 10.1007/s40291-018-0347-7. Review.

PMID:
29971646
9.

Role of epigenetics in Alzheimer's disease pathogenesis.

Stoccoro A, Coppedè F.

Neurodegener Dis Manag. 2018 Jun;8(3):181-193. doi: 10.2217/nmt-2018-0004. Epub 2018 Jun 11. Review.

PMID:
29888987
10.

Using Drosophila Models of Amyloid Toxicity to Study Autophagy in the Pathogenesis of Alzheimer's Disease.

O'Keefe L, Denton D.

Biomed Res Int. 2018 May 20;2018:5195416. doi: 10.1155/2018/5195416. eCollection 2018. Review.

11.

Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study.

Lanza G, Centonze SS, Destro G, Vella V, Bellomo M, Pennisi M, Bella R, Ciavardelli D.

Complement Ther Med. 2018 Jun;38:74-78. doi: 10.1016/j.ctim.2018.04.013. Epub 2018 May 5.

PMID:
29857884
12.

Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.

Duncan RS, Song B, Koulen P.

Int J Mol Sci. 2018 May 31;19(6). pii: E1621. doi: 10.3390/ijms19061621. Review.

13.

Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis.

Ling J, Yang S, Huang Y, Wei D, Cheng W.

Medicine (Baltimore). 2018 Jun;97(22):e10775. doi: 10.1097/MD.0000000000010775.

14.

The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.

Salminen A, Kaarniranta K, Kauppinen A.

Cell Mol Life Sci. 2018 Sep;75(17):3099-3120. doi: 10.1007/s00018-018-2844-6. Epub 2018 May 19. Review.

PMID:
29779041
15.

Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder.

Lozupone M, La Montagna M, D'Urso F, Piccininni C, Sardone R, Dibello V, Giannelli G, Solfrizzi V, Greco A, Daniele A, Quaranta N, Seripa D, Bellomo A, Logroscino G, Panza F.

Expert Opin Pharmacother. 2018 Jun;19(8):823-842. doi: 10.1080/14656566.2018.1471136. Epub 2018 May 4. Review.

PMID:
29726758
16.

Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.

Guimas Almeida C, Sadat Mirfakhar F, Perdigão C, Burrinha T.

Cell Mol Life Sci. 2018 Jul;75(14):2577-2589. doi: 10.1007/s00018-018-2825-9. Epub 2018 Apr 27. Review.

PMID:
29704008
17.

Sunlight Incidence, Vitamin D Deficiency, and Alzheimer's Disease.

Câmara AB, de Souza ID, Dalmolin RJS.

J Med Food. 2018 Sep;21(9):841-848. doi: 10.1089/jmf.2017.0130. Epub 2018 Mar 22. Review.

PMID:
29565713
18.

Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.

Lin L, Zheng LJ, Zhang LJ.

Mol Neurobiol. 2018 Nov;55(11):8243-8250. doi: 10.1007/s12035-018-0983-2. Epub 2018 Mar 9. Review.

PMID:
29524051
19.

Primer in Genetics and Genomics, Article 7-Multifactorial Concepts: Gene-Gene Interactions.

Stanfill AG, Starlard-Davenport A.

Biol Res Nurs. 2018 May;20(3):359-364. doi: 10.1177/1099800418761098. Epub 2018 Mar 7.

PMID:
29514459
20.

A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans.

McAninch EA, Rajan KB, Evans DA, Jo S, Chaker L, Peeters RP, Bennett DA, Mash DC, Bianco AC.

J Clin Endocrinol Metab. 2018 May 1;103(5):1818-1826. doi: 10.1210/jc.2017-01196.

PMID:
29481662

Supplemental Content

Loading ...
Support Center